SubHero Banner
Text

Bkemv™ (eculizumab-aeeb) – New first-time interchangeable biosimilar approval

May 28, 2024 - The FDA approved Amgen’s Bkemv (eculizumab-aeeb), biosimilar and interchangeable to AstraZeneca’s Soliris® (eculizumab).

Download PDF

 

Text